(RTTNews) - Coherent Corp. (COHR), a global manufacturer in laser and photonic solutions, has unveiled new pin-hole array biochips designed for medical diagnostics, particularly gene sequencing applications.
Developed by Coherent's advanced optics team, these biochips streamline the production process, addressing critical challenges in cost, efficiency, and supply chain management within the diagnostics industry.
Pin-hole array biochips play a vital role in medical diagnostics, disease prediction, clinical treatment, drug development, and food safety testing.
Coherent's pin-hole array biochips are available in diverse formats, from bare wafers to fully assembled modules, providing unmatched flexibility for various customer needs. This adaptability accelerates project timelines and enhances operational efficiency.
COHR closed Wednesday's trading at $107.96 up 4.17 percent or $4.31 on the Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
